Gang Chen

Gang Chen


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2017 in Annals of General Psychiatry
Verified
Journal Article
Open access
PDF file
CWCongjie Wang
Congjie Wang
WSWenjie Shi
Wenjie Shi
CHChengbing Huang
Chengbing Huang
JZJiannan Zhu
Jiannan Zhu
WHWenzhong Huang
Wenzhong Huang
GCGang Chen
Gang Chen
Differences in effectiveness and tolerability between different atypical antipsychotics may affect schizophrenic patients’ treatment adherence or prognosis. However, which kind of antipsychotic was more effective and safe in the treatment of schizophrenia is still being debated. This study attempted to understand whether there are any differences in efficacy, acceptability, and safety between the five atypical antipsychotics in patients with first-episode schizophrenia. Two hundred cases of inpatients with first-episode drug-naïve schizophrenia were randomly assigned to 6–8 weeks of treatment with either of aripiprazole, risperidone, quetiapine, olanzapine, or ziprasidone from October 2012 to November 2014. The efficacy, acceptability, and safety measurement after 6–8 weeks of treatment of the five kinds of antipsychotics were evaluated by the deduction rate of Brief Psychiatric Rating Scale (BPRS) total score, the proportion of treatment discontinuation, and adverse events, respectively. Whether the treatment discontinuation or combination therapy for baseline antipsychotics after titration mainly depended on ineffective or less effective on an initial-assigned antipsychotic during the study period. BPRS total scores in each antipsychotic group were significantly decreased at the end of the study (P < 0.01), and only the deduction rate of BPRS total scores in the risperidone group was markedly higher than those in the groups of aripiprazole (P < 0.01) and olanzapine (P < 0.05) after controlling the impact of the differences of age of onset. There were significant differences between quetiapine (χ 2 = 5.46, P = 0.019), olanzapine (χ 2 = 5.6, P = 0.018), and ziprasidone regarding the proportion of maintaining on initially allocated therapy. In addition, the difference in treatment discontinuation between male and female patients was also significant (χ 2 = 9.897, P = 0.002), and odds ratio of treatment discontinuation in male and female patients was 0.37 (95% CI 0.198–0.693); however, no difference in treatment discontinuation was found between five antipsychotics. Extrapyramidal symptoms in the groups of quetiapine and olanzapine were notably less than the other three kinds of antipsychotics (P < 0.05), but there were no significant differences in other adverse events between the five antipsychotic groups. Risperidone was more effective than aripiprazole and olanzapine in treating first-episode schizophrenia. The present study revealed the superiority of quetiapine and olanzapine over ziprasidone with remarkably less severe extrapyramidal adverse effects, especially with lower drop-out and treatment discontinuation. There were no differences in terms of other adverse events although the risk of treatment discontinuation was higher in female patients. Trial registration 2012-3-88. Registered 20 July 2012

1 December 2023 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
GCGang Chen
Gang Chen
LLLei Li
Lei Li
TSTaipeng Sun
Taipeng Sun
CJChenguang Jiang
Chenguang Jiang
WXWei Xu
Wei Xu
YYYonggui Yuan
Yonggui Yuan
Background: Depression is a heritable brain disorder. Laminin genes were recently identified to affect the brain’s overall thickness through neurogenesis, differentiation, and migration in depression. This study aims to explore the effects of the LAMA2’s single nucleotide polymorphisms (SNP), a subunit gene of laminin, on the detected brain regions of patients with major depressive disorder (MDD). Methods: The study included 89 patients with MDD and 60 healthy controls with T1-weighted structural magnetic resonance imaging and blood samples for genotyping. The interactions between LAMA2 gene SNPs and diagnosis as well as duration of illness (DOI) were explored on brain measures controlled for age, gender, and site. Results: The right transverse temporal gyrus and right parahippocampal gyrus showed reduced thickness in MDD. Almost all seven LAMA2 SNPs showed significant interactions with diagnosis on both gyrus (corrected p < 0.05 or trending). In MDD, rs6569604, rs2229848, rs2229849, rs2229850, and rs2784895 interacted with DOI on the right transverse temporal gyrus (corrected p < 0.05), but not the right parahippocampal gyrus. Conclusion: The thickness of the right transverse temporal gyrus in patients with MDD may be affected by LAMA2 gene and DOI.

7 August 2025 in BMC Public Health
Verified
Journal Article
Open access
PDF file
TSTaipeng Sun
Taipeng Sun
PLPan Liu
Pan Liu
SSSulin Shan
Sulin Shan
YRYan Ren
Yan Ren
ZZZhi Zhen
Zhi Zhen
LJLihua Jiang
Lihua Jiang
The coronavirus disease 2019 (COVID-19) pandemic has caused increased psychological problems in Group-living people, such as university students. The current epidemic of COVID-19 has become the new normal. The more tailored approach focused on Triggers and key points of emotion regulation may be helpful for the mental health of group-living people. This study aims to investigate the prevalence of symptoms of Depression, Anxiety, Anhedonia, and Perceived Stress. Further analyses were used to find their risk factors and their inter-relationships. An online, cross-sectional survey was undertaken with university students from five universities in China by The Depression Anxiety Stress Scales (DASS), Perceived Stress Scale (PSS), and Snaith-Hamilton Pleasure Scale (SHAPS). The Mann-Whitney U test was used to analyze differences between male and female students. Multiple linear regression analysis was applied to examine the related factors of anhedonia. Additionally, multigroup mediation models were used to analyze the relationship between perceived stress, anhedonia, stress, and depression. A total of 3,568 valid questionnaires were returned, and 814 (22.81%) with mild to moderate depressive symptoms, 114 (3.20%) with severe depressive symptoms; 840 (23.54%) with mild to moderate anxiety, and 235 (6.59%) with severe anxiety; 366 (10.26%) with mild to moderate stress, and 80 (2.24%) with severe stress. Interestingly, the levels of stress, anxiety, and anhedonia were higher in female students than in male students. The Multiple linear regression showed that anhedonia scores were correlated with PSS scores, DASS-depression scores, and females. Perceived Stress plays a negative mediating role between DASS-stress and anhedonia. Furthermore, Perceived Stress also plays a negative mediating role between stress and depression, but this effect was present only in individuals with mild to moderate depression. The finding of this cross-sectional study suggested that there were high prevalence rates of depression and anxiety symptoms in university students from China during the COVID-19 new normal. Early perceived stress was associated with the progress of depression and anhedonia.

18 February 2026 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
YYYucheng Yuan
Yucheng Yuan
LLLei Li
Lei Li
YZYubo Zhang
Yubo Zhang
GSGuangwei Sun
Guangwei Sun
TSTaipeng Sun
Taipeng Sun
GCGang Chen
Gang Chen

9 July 2025 in Journal of Clinical and Basic Psychosomatics
Verified
Journal Article
Open access
PDF file
SSS. Mudasser Shah
S. Mudasser Shah
CTChand Taneja
Chand Taneja
CJChenguang Jiang
Chenguang Jiang
WXWei Xu
Wei Xu
STSun Taipeng
Sun Taipeng
YYYonggui Yuan
Yonggui Yuan
Psychosomatic refers to an illness in which stress causes or exacerbates physical symptoms, and it may occur in transient or along with more acute mood disorders. The current study aimed to enhance understanding of the prevalence and cultural factors affecting psychosomatic symptoms, depression, and anxiety in China and Pakistan. A comparative cross-cultural study was conducted using a non-probability sampling technique. A total of 1633 samples were collected, including 598 healthy controls (300 from China and 298 from Pakistan) and 1035 patients (521 from China and 514 from Pakistan). Three assessment tools were utilized: Psychosomatic symptom scale (PSSS), patient health questionnaire-9, and generalized anxiety disorder-7. There were significant differences in the symptoms of patients and control groups with psychosomatic symptoms, depression, and anxiety in both countries. Post hoc testing revealed that Pakistani patients with mood disorders reported more psychosomatic symptoms than Chinese patients (p<0.001), whereas the Chinese control group had more psychosomatic symptoms than the Pakistani control group (p=0.001). Analysis of PSSS ratings in Chinese patients demonstrated a strong correlation between “depressed mood” and “loss of interest.” Pakistani PSSS displayed strong correlations on the somatic subscale and psychological subscale. In the present study, Pakistani patients exhibited higher levels of psychosomatic complaints, depression, and anxiety compared to Chinese patients. Notably, network analysis reveals that Pakistani patients displayed more physical symptoms, whereas Chinese patients experienced more psychological symptoms.